tiprankstipranks
Indaptus to sell 1.82M shares at $1.175 in registered direct offering
PremiumThe FlyIndaptus to sell 1.82M shares at $1.175 in registered direct offering
3M ago
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
Premium
The Fly
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
3M ago
Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
Premium
The Fly
Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
3M ago
Indaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
PremiumThe FlyIndaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
4M ago
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
Premium
The Fly
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
4M ago
Indaptus Therapeutics files to sell 1.64M shares of common stock for holders
Premium
The Fly
Indaptus Therapeutics files to sell 1.64M shares of common stock for holders
5M ago
Indaptus Therapeutics Elects Directors and Approves Key Proposals
PremiumCompany AnnouncementsIndaptus Therapeutics Elects Directors and Approves Key Proposals
9M ago
Indaptus Therapeutics announces updated data from Phase 1 Decoy20 trial
Premium
The Fly
Indaptus Therapeutics announces updated data from Phase 1 Decoy20 trial
9M ago
Indaptus Therapeutics to present new cohort data on Phase 1 trial of Decoy20
Premium
The Fly
Indaptus Therapeutics to present new cohort data on Phase 1 trial of Decoy20
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100